|
|
Conference:
Pre-conference workshop
1 Dec 9am - 5pm
Day 1
2 Dec 8.30am - 5:30pm
Day 2
3 Dec 8.30am - 5:30pm
Post-conference workshop
4 Dec 8.30am - 5:30pm
Venue:
The Bloomsbury Hotel, London, United Kingdom
› Email a friend
› Add this to my calendar
|
|
|
 Kaisa Tapale,
Therapy Lead, Oncology Eli Lilly, China Kaisa Taipale works as Therapy Area Lead for Health Outcomes research in Oncology for Europe in Eli Lilly and Company. Kaisa joined Lilly in 2001 from the National Research and Development Centre for Welfare and Health in Finland, where she worked as a researcher. During her career in Lilly, Kaisa has worked in Health Outcomes, pricing, reimbursement and access roles at an affiliate, global and regional levels supporting compounds over the drug life cycle. Kaisa Taipale has a Master of Science degree in Health Economics from the University of York, UK and a Master of Science in Economics and Business Administration from University of Vaasa, Finland.Appearing: Day Two - Thursday 3 December 2009 09.30 The use of observational research in late phaseTherapy Lead, Oncology,
Eli Lilly, China |
|
|
|
|
Dr Ellen Strahlman
Chief Medical Officer
GlaxoSmithKline
Dr Clive Morris
Medical Science Director
AstraZeneca
Mark Latymer
Scientific Advisor
Pfizer
Amy Sing
Associate Group Director - Post Marketing
Genentech
Professor Markus Kosch
Associate Medical Director
Wyeth Pharma
|
|
|
|
|
|
|
|
|
